Sarissa Capital Management LP - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 59 filers reported holding VOR BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Sarissa Capital Management LP ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,310,160
-31.4%
618,0000.0%0.18%
-7.4%
Q2 2023$1,909,620
-42.6%
618,0000.0%0.19%
-55.3%
Q1 2023$3,324,840
-19.1%
618,0000.0%0.42%
-13.1%
Q4 2022$4,109,700
+67.1%
618,0000.0%0.49%
+75.9%
Q3 2022$2,460,000
-19.9%
618,0000.0%0.28%
-10.0%
Q2 2022$3,071,000
-28.1%
618,000
-12.6%
0.31%
-23.5%
Q1 2022$4,270,000
-48.0%
707,0100.0%0.40%
-43.2%
Q4 2021$8,215,000
-25.9%
707,0100.0%0.71%
-18.3%
Q3 2021$11,086,000
-15.9%
707,0100.0%0.87%
-17.0%
Q2 2021$13,186,000
-56.7%
707,0100.0%1.05%
-64.1%
Q1 2021$30,472,000707,0102.92%
Other shareholders
VOR BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$34,226,0708.75%
OUP Management Co., LLC 374,714$2,015,9614.02%
Paradigm Biocapital Advisors LP 6,477,999$34,851,6353.30%
RA Capital Management 22,748,880$122,388,9742.77%
JOHNSON & JOHNSON 1,074,658$5,781,6601.88%
Artal Group S.A. 2,792,805$15,0250.89%
Trustees of Columbia University in the City of New York 91,910$494,4760.88%
Sarissa Capital Management LP 618,000$3,324,8400.42%
Laurion Capital Management LP 3,182,889$17,123,9430.12%
Woodline Partners LP 1,111,123$5,977,8420.08%
View complete list of VOR BIOPHARMA INC shareholders